FDA Advisory Committee Recommends Approval of KALYDECO for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation )--FDA Advisory Committee Recommends Approval of KALYDECO for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation )--Fitch Ratings rates GE Dealer Floorplan Master Note Trust , series 2014-2 as follows: --$500,000,000 class A notes 'AAAsf'; Outlook Stable; --$10,526,316 class ... )--Fitch Ratings assigns a 'AA+' to the following South Valley Sewer District, UT obligations: --$49.465 million sewer revenue refunding bonds series 2014.